홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /반응

Trifluoroacetic acid → 2-(3-Piperidin-4-ylmethyl-[1,2,4]oxadiazol-5-yl)furo[3,2-c]pyridine

HRID 217172
인쇄

반응식

HRID 217172 반응식
C(O)(C(F)(F)F)=O.C(OC([N:15]1[CH2:20][CH2:19][CH:18]([CH2:21][C:22]2[N:26]=[C:25]([C:27]3[O:35][C:34]4[CH:33]=[CH:32][N:31]=[CH:30][C:29]=4[CH:28]=3)[O:24][N:23]=2)[CH2:17][CH2:16]1)=O)(C)(C)C>C(Cl)Cl>[NH:15]1[CH2:20][CH2:19][CH:18]([CH2:21][C:22]2[N:26]=[C:25]([C:27]3[O:35][C:34]4[CH:33]=[CH:32][N:31]=[CH:30][C:29]=4[CH:28]=3)[O:24][N:23]=2)[CH2:17][CH2:16]1
참가 물질실험 절차후처리출처 및 근거반응 노트

참가 물질

4

반응물 2

HCID 6422Trifluoroacetic acidHCID 576595624-(5-Furo[3,2-c]pyridin-2-yl-[1,2,4]oxadiazol-3-ylmethyl)piperidine-1-carboxylic acid tert-butyl ester

생성물 1

HCID 116305842-(3-Piperidin-4-ylmethyl-[1,2,4]oxadiazol-5-yl)furo[3,2-c]pyridine

시약·촉매·용매 1

HCID 6344Dichloromethane용매

실험 절차

TFA (10 mL) was added to a stirred solution of 4-(5-furo[3,2-c]pyridin-2-yl-[1,2,4]oxadiazol-3-ylmethyl)piperidine-1-carboxylic acid tert-butyl ester (Example 44, 1.76 g, 4.56 mmol) in anhydrous CH2Cl2 (20 mL). After 1 h, the solvents were removed under reduced pressure. The residue was taken up in CH2Cl-MeOH (9:1, 100 mL), before being washed with 2M NaOH (100 mL). The aqueous phase was extracted with CH2Cl2-MeOH (9:1, 2×100 mL), then the organic extracts were combined, dried (MgSO4), and concentrated to furnish the title compound: m/z (ES+)=285.0 [M+H]+.

후처리

  1. customthe solvents were removed under reduced pressure
  2. washbefore being washed with 2M NaOH (100 mL)
  3. extractionThe aqueous phase was extracted with CH2Cl2-MeOH (9:1, 2×100 mL)
  4. dry with materialdried (MgSO4)
  5. concentrationconcentrated

출처 및 근거

ORD 기록
ord-de6df570550149789450fbf124e1e1c2
출처 데이터셋
uspto-grants-2012_06
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US08193359B2

반응 노트

이 페이지에서참가 물질실험 절차후처리출처 및 근거반응 노트